People channel feed

Mer­ck­'s Eli­av Barr on sub­cu­ta­neous Keytru­da, Sum­mit and deal shop­ping

8 months ago
R&D

Ar­bor Biotech­nolo­gies cuts ear­ly-stage dis­cov­ery work, lays off staff

8 months ago
R&D

Au­rinia re­struc­tures board, bring­ing in Kevin Tang and keep­ing CEO

8 months ago

Charles Riv­er to lay off 3% of staffers as it stream­lines spend­ing

8 months ago
Manufacturing

For­mer Ver­i­ly ex­ecs launch ef­fort to trans­form clin­i­cal tri­als

8 months ago
Financing
Health Tech

Lil­ly again hires from with­in for CFO post, el­e­vat­ing 23-year com­pa­ny vet­er­an

8 months ago
Pharma

Non-vi­ral de­liv­ery start­up Vesi­gen Ther­a­peu­tics trims staff as it eval­u­ates 's­trate­gic op­tion­s'

8 months ago
Startups
Pharma

Up­dat­ed: Lykos CEO Amy Emer­son re­signs

8 months ago

IN8bio paus­es glioblas­toma pro­gram, halves work­force as it pri­or­i­tizes leukemia as­set

8 months ago
R&D

Dana-Far­ber chief Lau­rie Glim­ch­er set to leave sto­ried can­cer cen­ter

8 months ago

Three Dyne ex­ec­u­tives leave as com­pa­ny re­ports new Duchenne drug da­ta

8 months ago
R&D

Pre­clin­i­cal team hit hard­est in Re­pare's R&D pri­or­i­ti­za­tion, lay­offs

8 months ago
R&D

Bio­Marin lays off 225 em­ploy­ees as it cuts spend­ing on gene ther­a­py roll­out

8 months ago
Pharma

Gene edit­ing start­up Tome Bio­sciences to lay off al­most all work­ers

9 months ago

Q&A: GSK CSO Tony Wood on stay­ing out of obe­si­ty, 'care­ful' can­cer am­bi­tions, and AI's fu­ture in R&D

9 months ago
R&D
Pharma

Up­dat­ed: Chi­nese gov­ern­ment in­dicts Japan­ese Astel­las em­ploy­ee for es­pi­onage

9 months ago
China

Bio­Marin shakes up ex­ec­u­tive team, tap­ping no­table deal­mak­er James Sabry

9 months ago
Pharma

Aa­di says its sol­id tu­mor drug is un­like­ly to suc­ceed, wind­ing down the tri­al and ax­ing staffers

9 months ago
R&D

Car­bon Health CEO Eren Bali steps down

9 months ago
Health Tech

Q&A: Lykos just cut 75% of its work­force af­ter an FDA re­jec­tion. Here’s what the CEO has to say

9 months ago
Pharma

Es­pe­ri­on's CMO hits the ex­it; Pfiz­er ap­points Nvidia alum as AI chief

9 months ago
Peer Review

Genen­tech dis­solves can­cer im­munol­o­gy group, and re­search ex­ec­u­tive Ira Mell­man will leave com­pa­ny

9 months ago
Pharma

Up­dat­ed: Lykos cut­ting most of staff less than a week af­ter FDA re­jec­tion

9 months ago
FDA+

Ace­lyrin sheds pipeline, lays off 33% of staff three months af­ter CEO de­par­ture

9 months ago
R&D
First page Previous page 6789101112 Next page Last page
A service from the Financial Times